HEADER BLOOD CLOTTING 18-NOV-19 6V09 TITLE CRYSTAL STRUCTURE OF HUMAN RECOMBINANT BETA-2 GLYCOPROTEIN I SHORT TAG TITLE 2 (ST-B2GPI) COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-2-GLYCOPROTEIN 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: APC INHIBITOR,ACTIVATED PROTEIN C-BINDING PROTEIN, COMPND 5 ANTICARDIOLIPIN COFACTOR,APOLIPOPROTEIN H,APO-H,BETA-2-GLYCOPROTEIN COMPND 6 I,BETA(2)GPI; COMPND 7 ENGINEERED: YES; COMPND 8 OTHER_DETAILS: SLAFW IS DISORDERED IN THE ELECTRON DENSITIES OF COMPND 9 COORDINATES. EDQVDPRLIDGK IS THE PURIFICATION TAG. EDQVDPRLI IS COMPND 10 DISORDERED IN THE ELECTRON DENSITIES OF COORDINATES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: APOH, B2G1; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: HEK293 KEYWDS PLASMA GLYCOPROTEIN, COAGULATION, INNATE IMMUNE SYSTEM, AUTOIMMUNITY, KEYWDS 2 THROMBOSIS, SUSHI DOMAIN, BLOOD CLOTTING EXPDTA X-RAY DIFFRACTION AUTHOR Z.CHEN,E.A.RUBEN,W.PLANER,M.CHINNARAJ,X.ZUO,V.PENGO,P.MACOR, AUTHOR 2 F.TEDESCO,N.POZZI REVDAT 5 11-OCT-23 6V09 1 REMARK REVDAT 4 12-AUG-20 6V09 1 JRNL HETSYN REVDAT 3 29-JUL-20 6V09 1 COMPND REMARK HETNAM LINK REVDAT 3 2 1 SITE ATOM REVDAT 2 24-JUN-20 6V09 1 JRNL REVDAT 1 17-JUN-20 6V09 0 JRNL AUTH E.RUBEN,W.PLANER,M.CHINNARAJ,Z.CHEN,X.ZUO,V.PENGO, JRNL AUTH 2 V.DE FILIPPIS,R.K.ALLURI,K.R.MCCRAE,P.MACOR,F.TEDESCO, JRNL AUTH 3 N.POZZI JRNL TITL THE J-ELONGATED CONFORMATION OF BETA2-GLYCOPROTEIN I JRNL TITL 2 PREDOMINATES IN SOLUTION: IMPLICATIONS FOR OUR UNDERSTANDING JRNL TITL 3 OF ANTIPHOSPHOLIPID SYNDROME. JRNL REF J.BIOL.CHEM. V. 295 10794 2020 JRNL REFN ESSN 1083-351X JRNL PMID 32518155 JRNL DOI 10.1074/JBC.RA120.013939 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH R.SCHWARZENBACHER,K.ZETH,K.DIEDERICHS,A.GRIES,G.M.KOSTNER, REMARK 1 AUTH 2 P.LAGGNER,R.PRASSL REMARK 1 TITL CRYSTAL STRUCTURE OF HUMAN BETA2-GLYCOPROTEIN I: REMARK 1 TITL 2 IMPLICATIONS FOR PHOSPHOLIPID BINDING AND THE REMARK 1 TITL 3 ANTIPHOSPHOLIPID SYNDROME. REMARK 1 REF EMBO J. V. 18 6228 1999 REMARK 1 REFN ISSN 0261-4189 REMARK 1 PMID 10562535 REMARK 1 DOI 10.1093/EMBOJ/18.22.6228 REMARK 2 REMARK 2 RESOLUTION. 2.99 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0158 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.99 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 116.98 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 3 NUMBER OF REFLECTIONS : 29924 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.224 REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1611 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.99 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.06 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2101 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.33 REMARK 3 BIN R VALUE (WORKING SET) : 0.3470 REMARK 3 BIN FREE R VALUE SET COUNT : 97 REMARK 3 BIN FREE R VALUE : 0.4070 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2517 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 236 REMARK 3 SOLVENT ATOMS : 15 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 75.41 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.92000 REMARK 3 B22 (A**2) : 3.08000 REMARK 3 B33 (A**2) : -4.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.264 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.230 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.183 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.795 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.918 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.889 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2863 ; 0.011 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 2452 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3921 ; 1.758 ; 2.075 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5783 ; 0.985 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 322 ; 7.596 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 103 ;30.179 ;24.175 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 428 ;19.049 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;16.058 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 450 ; 0.080 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2915 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 518 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6V09 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-NOV-19. REMARK 100 THE DEPOSITION ID IS D_1000245466. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-APR-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : CU FINE FOCUS REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31543 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.990 REMARK 200 RESOLUTION RANGE LOW (A) : 116.980 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.09500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.46100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1C1Z REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 88.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 10.8 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM HEPES, 1.5 M AMSO4, 20 MM CACL2 REMARK 280 AND 2% GLYCEROL, PH 7.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.68450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 56.68450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 80.12400 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 85.58000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 80.12400 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 85.58000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 56.68450 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 80.12400 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 85.58000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 56.68450 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 80.12400 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 85.58000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 514 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 515 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A -11 REMARK 465 ASP A -10 REMARK 465 GLN A -9 REMARK 465 VAL A -8 REMARK 465 ASP A -7 REMARK 465 PRO A -6 REMARK 465 ARG A -5 REMARK 465 LEU A -4 REMARK 465 ILE A -3 REMARK 465 SER A 312 REMARK 465 LEU A 313 REMARK 465 ALA A 314 REMARK 465 PHE A 315 REMARK 465 TRP A 316 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 11 122.48 -35.53 REMARK 500 ARG A 39 105.86 -48.67 REMARK 500 PRO A 54 -177.14 -61.77 REMARK 500 ALA A 68 30.73 -140.62 REMARK 500 THR A 79 -80.32 -88.70 REMARK 500 PHE A 81 39.84 -91.52 REMARK 500 PRO A 113 -176.52 -66.48 REMARK 500 ARG A 148 -4.01 72.36 REMARK 500 ASP A 149 172.12 -56.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1C1Z RELATED DB: PDB DBREF 6V09 A 1 326 UNP P02749 APOH_HUMAN 20 345 SEQADV 6V09 GLU A -11 UNP P02749 EXPRESSION TAG SEQADV 6V09 ASP A -10 UNP P02749 EXPRESSION TAG SEQADV 6V09 GLN A -9 UNP P02749 EXPRESSION TAG SEQADV 6V09 VAL A -8 UNP P02749 EXPRESSION TAG SEQADV 6V09 ASP A -7 UNP P02749 EXPRESSION TAG SEQADV 6V09 PRO A -6 UNP P02749 EXPRESSION TAG SEQADV 6V09 ARG A -5 UNP P02749 EXPRESSION TAG SEQADV 6V09 LEU A -4 UNP P02749 EXPRESSION TAG SEQADV 6V09 ILE A -3 UNP P02749 EXPRESSION TAG SEQADV 6V09 ASP A -2 UNP P02749 EXPRESSION TAG SEQADV 6V09 GLY A -1 UNP P02749 EXPRESSION TAG SEQADV 6V09 LYS A 0 UNP P02749 EXPRESSION TAG SEQRES 1 A 338 GLU ASP GLN VAL ASP PRO ARG LEU ILE ASP GLY LYS GLY SEQRES 2 A 338 ARG THR CYS PRO LYS PRO ASP ASP LEU PRO PHE SER THR SEQRES 3 A 338 VAL VAL PRO LEU LYS THR PHE TYR GLU PRO GLY GLU GLU SEQRES 4 A 338 ILE THR TYR SER CYS LYS PRO GLY TYR VAL SER ARG GLY SEQRES 5 A 338 GLY MET ARG LYS PHE ILE CYS PRO LEU THR GLY LEU TRP SEQRES 6 A 338 PRO ILE ASN THR LEU LYS CYS THR PRO ARG VAL CYS PRO SEQRES 7 A 338 PHE ALA GLY ILE LEU GLU ASN GLY ALA VAL ARG TYR THR SEQRES 8 A 338 THR PHE GLU TYR PRO ASN THR ILE SER PHE SER CYS ASN SEQRES 9 A 338 THR GLY PHE TYR LEU ASN GLY ALA ASP SER ALA LYS CYS SEQRES 10 A 338 THR GLU GLU GLY LYS TRP SER PRO GLU LEU PRO VAL CYS SEQRES 11 A 338 ALA PRO ILE ILE CYS PRO PRO PRO SER ILE PRO THR PHE SEQRES 12 A 338 ALA THR LEU ARG VAL TYR LYS PRO SER ALA GLY ASN ASN SEQRES 13 A 338 SER LEU TYR ARG ASP THR ALA VAL PHE GLU CYS LEU PRO SEQRES 14 A 338 GLN HIS ALA MET PHE GLY ASN ASP THR ILE THR CYS THR SEQRES 15 A 338 THR HIS GLY ASN TRP THR LYS LEU PRO GLU CYS ARG GLU SEQRES 16 A 338 VAL LYS CYS PRO PHE PRO SER ARG PRO ASP ASN GLY PHE SEQRES 17 A 338 VAL ASN TYR PRO ALA LYS PRO THR LEU TYR TYR LYS ASP SEQRES 18 A 338 LYS ALA THR PHE GLY CYS HIS ASP GLY TYR SER LEU ASP SEQRES 19 A 338 GLY PRO GLU GLU ILE GLU CYS THR LYS LEU GLY ASN TRP SEQRES 20 A 338 SER ALA MET PRO SER CYS LYS ALA SER CYS LYS VAL PRO SEQRES 21 A 338 VAL LYS LYS ALA THR VAL VAL TYR GLN GLY GLU ARG VAL SEQRES 22 A 338 LYS ILE GLN GLU LYS PHE LYS ASN GLY MET LEU HIS GLY SEQRES 23 A 338 ASP LYS VAL SER PHE PHE CYS LYS ASN LYS GLU LYS LYS SEQRES 24 A 338 CYS SER TYR THR GLU ASP ALA GLN CYS ILE ASP GLY THR SEQRES 25 A 338 ILE GLU VAL PRO LYS CYS PHE LYS GLU HIS SER SER LEU SEQRES 26 A 338 ALA PHE TRP LYS THR ASP ALA SER ASP VAL LYS PRO CYS HET NAG B 1 14 HET NAG B 2 14 HET BMA B 3 11 HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET NAG A 401 14 HET NAG A 402 14 HET SO4 A 409 5 HET SO4 A 410 5 HET SO4 A 411 5 HET SO4 A 412 5 HET SO4 A 413 5 HET SO4 A 414 5 HET SO4 A 415 5 HET SO4 A 416 5 HET SO4 A 417 5 HET SO4 A 418 5 HET SO4 A 419 5 HET SO4 A 420 5 HET SO4 A 421 5 HET SO4 A 422 5 HET SO4 A 423 5 HET SO4 A 424 5 HET SO4 A 425 5 HET SO4 A 426 5 HET SO4 A 427 5 HET SO4 A 428 5 HET SO4 A 429 5 HET SO4 A 430 5 HET SO4 A 431 5 HET SO4 A 432 5 HET SO4 A 433 5 HET SO4 A 434 5 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM SO4 SULFATE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 2 NAG 6(C8 H15 N O6) FORMUL 2 BMA 2(C6 H12 O6) FORMUL 6 SO4 26(O4 S 2-) FORMUL 32 HOH *15(H2 O) HELIX 1 AA1 ILE A 263 PHE A 267 1 5 HELIX 2 AA2 ASP A 319 VAL A 323 5 5 SHEET 1 AA1 2 CYS A 4 PRO A 5 0 SHEET 2 AA1 2 PHE A 21 TYR A 22 -1 O TYR A 22 N CYS A 4 SHEET 1 AA2 3 SER A 13 VAL A 16 0 SHEET 2 AA2 3 GLU A 27 CYS A 32 -1 O THR A 29 N VAL A 16 SHEET 3 AA2 3 LYS A 44 ILE A 46 -1 O PHE A 45 N ILE A 28 SHEET 1 AA3 2 TYR A 36 SER A 38 0 SHEET 2 AA3 2 CYS A 60 PRO A 62 -1 O THR A 61 N VAL A 37 SHEET 1 AA4 4 GLY A 74 ARG A 77 0 SHEET 2 AA4 4 THR A 86 CYS A 91 -1 O SER A 90 N ALA A 75 SHEET 3 AA4 4 SER A 102 CYS A 105 -1 O ALA A 103 N ILE A 87 SHEET 4 AA4 4 TRP A 111 SER A 112 -1 O SER A 112 N LYS A 104 SHEET 1 AA5 2 PHE A 95 ASN A 98 0 SHEET 2 AA5 2 VAL A 117 PRO A 120 -1 O VAL A 117 N ASN A 98 SHEET 1 AA6 2 ILE A 122 CYS A 123 0 SHEET 2 AA6 2 SER A 145 LEU A 146 -1 O SER A 145 N CYS A 123 SHEET 1 AA7 3 ALA A 132 VAL A 136 0 SHEET 2 AA7 3 THR A 150 CYS A 155 -1 O GLU A 154 N THR A 133 SHEET 3 AA7 3 THR A 166 THR A 168 -1 O ILE A 167 N ALA A 151 SHEET 1 AA8 2 HIS A 159 PHE A 162 0 SHEET 2 AA8 2 GLU A 180 GLU A 183 -1 O ARG A 182 N ALA A 160 SHEET 1 AA9 2 LYS A 185 CYS A 186 0 SHEET 2 AA9 2 LEU A 205 TYR A 206 -1 O LEU A 205 N CYS A 186 SHEET 1 AB1 3 GLY A 195 ASN A 198 0 SHEET 2 AB1 3 LYS A 210 CYS A 215 -1 O THR A 212 N ASN A 198 SHEET 3 AB1 3 GLU A 226 GLU A 228 -1 O ILE A 227 N ALA A 211 SHEET 1 AB2 2 TYR A 219 LEU A 221 0 SHEET 2 AB2 2 CYS A 241 ALA A 243 -1 O LYS A 242 N SER A 220 SHEET 1 AB3 4 GLU A 259 LYS A 262 0 SHEET 2 AB3 4 THR A 253 TYR A 256 -1 N VAL A 254 O VAL A 261 SHEET 3 AB3 4 LYS A 276 ASN A 283 -1 O SER A 278 N VAL A 255 SHEET 4 AB3 4 CYS A 288 GLN A 295 -1 O TYR A 290 N CYS A 281 SSBOND 1 CYS A 4 CYS A 47 1555 1555 2.09 SSBOND 2 CYS A 32 CYS A 60 1555 1555 2.09 SSBOND 3 CYS A 65 CYS A 105 1555 1555 2.04 SSBOND 4 CYS A 91 CYS A 118 1555 1555 2.11 SSBOND 5 CYS A 123 CYS A 169 1555 1555 2.04 SSBOND 6 CYS A 155 CYS A 181 1555 1555 2.09 SSBOND 7 CYS A 186 CYS A 229 1555 1555 2.05 SSBOND 8 CYS A 215 CYS A 241 1555 1555 2.08 SSBOND 9 CYS A 245 CYS A 296 1555 1555 2.09 SSBOND 10 CYS A 281 CYS A 306 1555 1555 2.50 SSBOND 11 CYS A 288 CYS A 326 1555 1555 2.05 LINK ND2 ASN A 143 C1 NAG A 401 1555 1555 1.46 LINK ND2 ASN A 164 C1 NAG A 402 1555 1555 1.48 LINK ND2 ASN A 174 C1 NAG C 1 1555 1555 1.41 LINK ND2 ASN A 234 C1 NAG B 1 1555 1555 1.38 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.48 LINK O4 NAG B 2 C1 BMA B 3 1555 1555 1.45 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.39 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.42 CISPEP 1 VAL A 16 PRO A 17 0 -11.02 CISPEP 2 TYR A 83 PRO A 84 0 -3.56 CISPEP 3 SER A 112 PRO A 113 0 -4.97 CRYST1 160.248 171.160 113.369 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006240 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005842 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008821 0.00000